Director/PDMR Shareholding
Source: RNS15 November 2024
Litigation Capital Management Limited
("LCM" or the "Company")
Exercise of Awards
Litigation Capital Management Limited (AIM:LIT), a leading international alternative asset manager of disputes financing solutions, announces that Susanna Taylor, a Person Discharging Managerial Responsibilities (PDMR) exercised loan shares over 274,648 ordinary shares which have been sold to the Employee Benefit Trust ('EBT').
The following table details the quantum of LSPs exercised which have been sold to the EBT:
Employee |
Position |
Incentive Scheme |
Number of Share/Options Awarded |
Susanna Taylor |
Head of APAC / PDMR |
LSP |
274,648 |
Non-PDMR Employees |
Various / Non-PDMR |
LSP |
509,871 |
Employee Benefit Trust ('EBT')
The Company has an EBT. The EBT is a discretionary trust for the benefit of the Company's employees, including the Directors of the Company. Following the purchase of the LSP's detailed above, the EBT of the Company currently holds 4,270,308 Ordinary Shares, representing 3.74 per cent. of the of the Company's total voting rights.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further details.
Enquiries
Litigation Capital Management |
c/o Tavistock |
Patrick Moloney, Chief Executive Officer David Collins, Chief Financial Officer |
|
|
|
Cavendish (Nomad and Joint Broker) |
Tel: 020 7220 0500 |
Jonny Franklin-Adams and Rory Sale (Corporate Finance) Tim Redfern and Jamie Anderson (Corporate Broking) |
|
|
|
Canaccord Genuity (Joint Broker) |
Tel: 020 7523 8000 |
Bobbie Hilliam |
|
|
|
Tavistock (PR and IR) |
Tel: 020 7920 3150 |
Katie Hopkins Simon Hudson |
lcm@tavistock.co.uk |
NOTES TO EDITORS
Litigation Capital Management (LCM) is an alternative asset manager specialising in disputes financing solutions internationally, which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is third party fund management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Portfolio funding and Acquisitions of claims. LCM generates its revenue from both its direct investments and also performance fees through asset management.
LCM has an unparalleled track record driven by disciplined project selection and robust risk management. Currently headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.
1. |
Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") |
|||||||
a) |
Name |
Susanna Taylor |
||||||
2. |
Reason for the notification |
|||||||
a) |
Position / status |
Head of APAC |
||||||
b) |
Initial notification / amendment |
Initial notification |
||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
a) |
Name |
Litigation Capital Management Limited |
||||||
b) |
Legal Entity Identifier |
213800J2B5SI8F515244 |
||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
a) |
Description of the financial instrument |
Loan shares |
||||||
b) |
Nature of the transaction |
Exercise and sale of loan shares |
||||||
c) |
Price(s) and volume(s) |
|
||||||
d) |
Aggregated information - Aggregated volume - Aggregated price - Aggregated total |
274,648 loan shares over ordinary shares 115.27p £316,586 |
||||||
e) |
Date of the transaction |
14 November 2024 (UK) |
||||||
f) |
Place of the transaction |
Outside a trading venue |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.